InvestorsHub Logo
icon url

tangerine

11/18/14 12:57 PM

#134878 RE: Hike #134877

Something occurred to me as I am currently shopping for Health insurance. If Oxycontin has no generic on the market. Then there is clearly a need for generics, desire to lower health care costs etc...

As opioid generics are eliminated or look to be substituted for ADT versions, it makes perfect sense that the FDA would push through these generic versions very quickly..Between the urgency over abuse and urgency over costs and needing ADT and generic choices, these drugs likely get pushed in an expedited manner.
icon url

dr_lowenstein

11/18/14 12:58 PM

#134879 RE: Hike #134877

never said it did not happen, please note it happened in 2011 for a treat the deadly disease CF. LOL LOL sheeze
icon url

no2koolaid

11/18/14 4:22 PM

#134919 RE: Hike #134877

Well done research support to the reality of expedited review. What was it the NY Times called it? "Lightening quick!" Elite may or may not be so fortunate, but clearly it lies within the realm of possibility. Particular in light of the fact that, in response to the socio-political dynamics related to opioid abuse, the FDA has made it clear that it wants ART/ADT as a precursor to future approvals.